AbbVie to invest $380 million to expand US manufacturing in Illinois

Feb 23 (Reuters) - AbbVie on Monday said it would invest $380 million to build two new active pharmaceutical ingredient ...

AbbVie to Invest $380 Million in North Chicago to Further Expand Active Pharmaceutical Ingredient Manufacturing in the United States

AbbVie (NYSE: ABBV) today announced a new $380 million investment to build two new active pharmaceutical ingredient (API) manufacturing facilities at its current North Chicago, Illinois, campus. These ...
Oman Observer

Building confidence in Oman’s oilfield manufacturing

MUSCAT, FEB 23As Oman advances its ambitions under Oman Vision 2040, the spotlight is increasingly shifting from mere ...
PharmTech

Fresenius Kabi and Phlow Corp. Enter First US End-to-End Manufacturing Collaboration

Phlow will manufacture epinephrine API in Virginia while Fresenius Kabi formulates and fills finished doses in existing US ...

Top Fine Chemicals Manufacturer Expands Production Capacity to Meet Growing Global Demand

HANGZHOU CITY, ZHEJIANG PROVINCE, CHINA, January 20, 2026 /EINPresswire.com/ -- The global fine chemicals industry is ...

Chinese Top 3 Semiconductor Precursor Processing Equipment Manufacturers Driving Innovation and Quality

Delivering Integrated Reaction, Crystallization, Filtration, and Drying Solutions for Advanced Semiconductor Materials ...

Numina Group Unveils Batchbot 2.0: AI Order Orchestration and Voice Picking for Smarter AMR Fulfillment

AI-powered RDS orchestration synchronizes AMRs and voice picking to deliver goods-to-person performance at a fraction ...

APi Group Corporation (APG) Presents at Barclays 43rd Annual Industrial Select Conference Transcript

Barclays 43rd Annual Industrial Select Conference February 18, 2026 7:30 AM ESTCompany ParticipantsRussell Becker - ...

Aspire Biopharma Secures Agreement with Microsize for Development of Novel Sublingual Aspirin

Microsize brings over thirty years of expertise in specialized particle size engineering for the pharmaceutical industry, from pre-clinical development to full-scale GMP commercial manufacturing.
BioProcess International

Risk-Assessing Manual Cleaning Processes To Reduce Error Rates in Biomanufacturing

Manual cleaning remains essential in biomanufacturing despite automation, requiring risk-assessed control strategies to prevent cross-contamination.
The Manila Times

Mapi Pharma to Host Virtual KOL Event to Discuss Glatiramer Acetate Once a Month Depot for Primary Progressive Multiple Sclerosis, on March 3, 2026

Mapi Pharma Ltd., a fully integrated, late-stage clinical development biopharmaceutical company focused on introducing innovative long-acting depot injectable treatments, today announced that it will ...